Management of Advanced Invasive Ovarian Cancer

	Tweet

At present, the treatment of choice for patients with advanced invasive epithelial ovarian cancer is cytoreductive surgery followed by six cycles of chemotherapy with a combination of carboplatin (AUC 5-6) and paclitaxel (175 mg/M₂ over 3 h) every 3 weeks (Table 118-8). Paclitaxel is administered before the carboplatin. In patients at risk for severe neuropathy, for example, diabetics, a combination of docetaxel (75 mg/M₂) and carboplatin (AUC 5) provides an alternative that is less neurotoxic. As data confirming the SCOTROC trial are obtained, the latter regimen may become a standard option for all patients. In women who cannot tolerate the toxicity of taxanes, carboplatin alone (AUC 6-7) can be given. For the rare patient who cannot tolerate IV chemotherapy, an oral alkylating agent can be used for palliation.

Management of Advanced Borderline Tumors
The effectiveness of chemotherapy in patients with advanced-stage borderline tumors has not been established. The GOG is evaluating the use of chemotherapy in patients with advanced-stage borderline tumors who have recurrent disease after initial surgery. Until the results of this trial are known, the current approach to treatment is primarily surgical. Patients should undergo cytoreductive surgery and observation. Borderline tumors, even in advanced stage, have a favorable prognosis. The first symptomatic recurrence may be several years after diagnosis. In contrast to the 20% to 25% survival rates for advanced epithelial invasive carcinoma of the ovary, the survival rate for patients with stage III borderline tumors is over 60%.277 Consequently, secondary cytoreductive surgery frequently will lead to another prolonged interval of symptom free survival. Chemotherapy can be administered to the patients in whom cytoreductive surgery is no longer feasible, although its efficacy is uncertain.

RELATED STORIES:
Assessment of Response in Patients who are Clinically free of Disease   Ovarian Cancer Prevention   Ovarian Cancer Embryology   Immunotherapy in Ovarian Cancer   Ovarian Cancer - Patterns of Spread   Chemotherapy for Advanced Stage Epithelial Ovarian Cancer   Consolidation Bhemotherapy and Immuno-therapy in Ovarian Cancer   Treatment of Early stage Ovarian Cancer   Ovarian Cancer Screening   Follow-up Examinations in Ovarian Cancer   Epithelial Ovarian Cancer   Genetic Risk for Epithelial Ovarian Cancer   Ovarian Cancer Classification and Pathology   Ovarian Cancer Etiology and Epidemiology   Treatment of Advanced Stage Epithelial Ovarian Cancer   Biology and Prognosis of Ovarian Neoplasms   Ovarian Cancer Clinical Features   Ovarian Cancer Diagnosis   Survival of Patients with Advanced Ovarian Cancer   Staging of Ovarian Cancer   Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer   Palliative Radiotherapy in Ovarian Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]